Maia Biotechnology Inc MAIA:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:49 PM EDT
4.00quote price arrow up+0.05 (+1.27%)
Volume
1,086
Close
3.95quote price arrow down-0.36 (-8.31%)
Volume
143,101
52 week range
3.78 - 9.64
Loading...
  • Open4.33
  • Day High4.45
  • Day Low3.95
  • Prev Close4.31
  • 52 Week High9.64
  • 52 Week High Date08/01/22
  • 52 Week Low3.78
  • 52 Week Low Date07/28/22

Key Stats

  • Market Cap43.21M
  • Shares Out10.94M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open4.33
  • Day High4.45
  • Day Low3.95
  • Prev Close4.31
  • 52 Week High9.64
  • 52 Week High Date08/01/22
  • 52 Week Low3.78
  • 52 Week Low Date07/28/22
  • Market Cap43.21M
  • Shares Out10.94M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-1.45
  • P/E (TTM)-2.73
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-10.179M
  • ROE (TTM)-
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Maia Biotechnology Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
MAIA Biotechnology, Inc. is a biopharmaceutical company that develops oncology drug candidates to improve and extend the lives of people with cancer. The Company’s pipeline includes several targeted immuno-oncology therapies for difficult-to-treat cancers. The Company's THIO (6-thio-dG, 6-thio-2’-deoxyguanosine) is a potentially first-in-class small molecule that is a telomere-by-telomerase targeting agent for the treatment of multiple cancer types. THIO is followed by...
Vlad Vitoc
Chairman of the Board, Chief Executive Officer
Joseph Mcguire
Chief Financial Officer
Address
444 West Lake Street
Suite 1700, Suite 1700
Chicago, IL
60606
United States